Navigating the Changing Landscape of Relapsed/Refractory Multiple Myeloma: Optimizing Treatment Strategies : Episode 7
R/R MM Treatment Landscape: Role of Bispecifics
Dr Nadeem discusses his case details and shares his initial thoughts. He then reviews the current treatment landscape for relapsed/refractory multiple myeloma, including his experience with bispecifics in practice and his challenges in using them.
EP: 1.R/R MM: Treating Patients with CNS Metastases Involvement
EP: 2.Optimal Dosing Strategies and Managing AEs
EP: 3.R/R MM: Bispecifics in R/R MM: Key Takeaways
EP: 4.R/R MM: Insights Into Optimal Dosing for Bispecifics
EP: 5.Bispecifics in R/R MM: AE Management and Sequencing
EP: 6.Future Perspectives in R/R MM
Now Viewing
EP: 7.R/R MM Treatment Landscape: Role of Bispecifics
EP: 8.Clinical Pearls Surrounding the Use of Bispecifics in R/R MM
Video content above is prompted by the following
Briefly discuss your case details and share your initial thoughts.
- Can you briefly review the current treatment landscape for patients with relapsed/refractory multiple myeloma?
- What has been your experience with using bispecifics in practice?
- What are the challenges you are seeing?
Recent Videos
Related Content
